Pieter‐Jan van Dam
Papers
2
Total Citations
63
H-Index
2
About
Pieter-Jan van Dam is a leading voice in gynecologic oncology, best known for his critical, evidence-based examination of surgical innovation. His primary research areas center on the cost-effectiveness and clinical utility of robot-assisted surgery in gynecological procedures, as well as advanced cytoreductive techniques for metastatic disease. Van Dam’s major contribution lies in his rigorous, data-driven challenge to the uncritical adoption of robotic technology. His most cited work, “Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?” (2011, 50 citations), is a landmark review that argues the exponential use of robotic surgery is driven more by manufacturers, patients, and enthusiastic surgeons than by evidence-based benefits. He demonstrated that robot-assisted surgery is consistently more expensive than video-laparoscopy without clear superiority in many cases, providing a crucial counterpoint to industry hype. Additionally, his work on “Robotic-assisted laparoscopic cytoreductive surgery for lobular carcinoma of the breast metastatic to the ovaries” (2007, 13 citations) showcases his technical expertise in applying these tools to complex, rare cases. Van Dam’s scholarship is essential for students and researchers seeking a balanced, critical perspective on the true value of emerging surgical technologies in oncology.
Research Focus
Key Achievements
Top Papers
- 1Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?50 citations · 2011
- 2